This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Suzhou Xuanjia Optics and Electronics Technology Co. Ltd., Zhongshan Ophthalmic Center, Sun Yat-Sen University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Mingguang He
Introduction
Mingguang He is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of ophthalmology through his innovative methods aimed at improving eye health. His work focuses on enhancing blood flow and metabolic rates in the eye fundus, which is crucial for maintaining optimal vision.
Latest Patents
Mingguang He holds a patent for a method designed to increase blood flow and metabolic rate of the eye fundus. This method involves irradiating the eye fundus through the pupil using red light or near-infrared light within specific wavelength and energy density ranges. The process includes an initial irradiation followed by repeated sessions at defined intervals, ensuring effective treatment for eye health.
Career Highlights
Throughout his career, Mingguang He has been associated with several prestigious institutions. He has worked at the Zhongshan Ophthalmic Center and Sun Yat-sen University, where he has contributed to research and development in ophthalmology. Additionally, he has been involved with Suzhou Xuanjia Optics and Electronics Technology Co. Ltd., further expanding his impact in the field.
Collaborations
Mingguang He has collaborated with notable colleagues, including Zhaoyun Cao and Zhuoting Zhu. These partnerships have fostered advancements in research and innovation within the ophthalmic sector.
Conclusion
Mingguang He exemplifies the spirit of innovation in the field of ophthalmology. His patented methods and collaborative efforts highlight his commitment to improving eye health and advancing medical technology. His contributions are invaluable to the ongoing research and development in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile